The Efficacy of Concentrated Growth Factor in the Healing of Alveolar Osteitis: A Clinical Study

Figure 1

Molecular mechanism of alveolar osteitis. Plasminogen type-1 is the precursor of plasmin which acts in fibrin degradation. Plasmin inhibitor sterically shields the active site of plasmin, thus substantially decreasing plasmin’s access to protein substrates [15]. t-PA: tissue-type plasminogen activator; FDP: fibrin degradation products.